Results 251 to 260 of about 81,608 (302)

The Impact of 3D Nichoids and Matrix Stiffness on Primary Malignant Mesothelioma Cells. [PDF]

Genes (Basel)
Oliveto S, Ritter P, Deroma G, Miluzio A, Cordiglieri C, Benvenuti MR, Mutti L, Raimondi MT, Biffo S.   +8 more
europepmc   +1 more source

Combined Inhibition of EZH2 and FGFR is Synergistic in BAP1-deficient Malignant Mesothelioma. [PDF]

Cancer Res Commun
Badhai J, Landman N, Pandey GK, Song JY, Hulsman D, Krijgsman O, Chandrasekaran G, Berns A, van Lohuizen M.   +8 more
europepmc   +1 more source

Confirmatory validation of a brief patient-reported outcome measure assessing psychological distress in caregivers of malignant mesothelioma patients: the Mesothelioma Psychological Distress Tool-Caregivers. [PDF]

Front Psychol
Granieri A, Franzoi IG, Sauta MD, Marinaccio A, Mensi C, Rugarli S, Migliore E, Cozzi I, Cavone D, Vimercati L, Grosso F, Bertolotti M, Raimondi G, Innamorati M, Bonafede M.   +14 more
europepmc   +1 more source

Peritoneal Malignant Mesothelioma Metastasizing to Lymph Node in Young Male-a Case Report. [PDF]

Indian J Surg Oncol
Singh A, Bansal C, Singla D, More S, Chabhra S, Bashir S.   +5 more
europepmc   +1 more source

Combining immunotherapy with radiation therapy in thoracic oncology [PDF]

, 2018
Badiyan, Shahed N, Chilukuri, Srinivas, Chuong, Michael D, Glass, Erica, Mohindra, Pranshu, Onyeuku, Nasarachi E, Remick, Jill, Rice, Stephanie R, Roach, Michael C, Simone, Charles B, II   +9 more
core   +1 more source

Safety and efficacy of PD-1/PD-L1 immune checkpoint inhibitors in patients with pre-treated advanced stage malignant mesothelioma: a systematic review and meta-analysis. [PDF]

BMC Cancer
Zafar A, Rashid AA, Moeed A, Tahir MJ, Khan AJ, Shrateh ON, Ahmed A.   +6 more
europepmc   +1 more source

Sarcomatoid Malignant Pleural Mesothelioma: A Case Report

Divya Sharma, Mayur Khandelwal, H. S. Kumar   +2 more
openalex   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Malignant mesothelioma

Lancet, The, 2005
Malignant mesothelioma is an aggressive, treatment-resistant tumour, which is increasing in frequency throughout the world. Although the main risk factor is asbestos exposure, a virus, simian virus 40 (SV40), could have a role. Mesothelioma has an unusual molecular pathology with loss of tumour suppressor genes being the predominant pattern of lesions,
Bruce W S, Robinson, Arthur W, Musk, Richard A, Lake   +2 more
exaly   +3 more sources